SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is facing heightened volatility and selling pressure as investors weigh recent short-seller allegations regarding material sourcing against large-scale infrastructure financing deals. While community discussions remain divided between concerns over regulatory roadblocks for data center power projects and bullish sentiment regarding the company's long-term role in solving energy bottlenecks for AI infrastructure, many market participants are actively watching key technical support levels for potential stabilization.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense debate as investors weigh the company's aggressive debt-fueled AI infrastructure spending and credit rating concerns against its massive cloud service backlog. The community is sharply divided, with some betting on a long-term turnaround fueled by enterprise demand, while others caution that the current volatility and high capital expenditures signal further downside risks.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is trending as investors react to the company's aggressive expansion into AI infrastructure, specifically the full commercialization of its massive Beacon Point data center campus in Texas through a landmark 15-year lease. Community sentiment remains polarized, with some bulls highlighting the company's strong long-term revenue visibility and status as a top-tier data center play, while others express frustration over institutional selling and market volatility that often erodes recent gains.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is drawing intense community focus as traders debate the disconnect between robust aircraft delivery numbers, key government contract wins, and the stock's persistent price volatility. Investors are actively discussing whether the company's long-term turnaround strategy and production ramp-up can overcome recent regulatory hurdles and institutional selling pressure ahead of upcoming earnings.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart Holdings is trending as retail investors engage in a heated, polarized debate over its volatile price action, with many discussing its struggle to maintain momentum compared to other fintech peers. The community is heavily focused on the stock's significant short interest, technical breakdown, and the high-stakes pressure building ahead of the next earnings release.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending as shareholders speculate on potential upcoming partnerships and the status of its proprietary COVID-Influenza Combination (CIC) vaccine ahead of the next earnings cycle. Community sentiment remains deeply divided, with some investors expressing frustration over management's lack of communication regarding pipeline assets, while others look to the strategic licensing of the Matrix-M adjuvant as a sign of long-term growth potential.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing significant trading activity following a major deal announcement, with the community actively debating whether the stock's recent volatility is a short-term trap or a long-term accumulation opportunity. Investors are heavily focused on the company's ability to convert its pipeline into sustainable revenue, with discussions revolving around hyperscaler partnerships and the ongoing infrastructure demand for AI compute capacity.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is trending as Tempus AI moves to acquire the company for approximately $1.5 billion, a strategic deal aimed at strengthening Tempus' oncology and precision medicine platform. While the acquisition provides a floor for the stock price, shareholders are actively debating whether the valuation represents a fair premium or a missed opportunity for a potential bidding war from other oncology leaders.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is seeing intense community discussion and high volume as investors monitor its Ibtrozi commercial launch and the promising Phase 3 development of its glioma candidate, safusidenib. While volatility persists, the community remains focused on the company's strong cash position, potential for future M&A, and the leadership of a CEO with a proven track record of biotech acquisitions.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as investors anticipate key clinical and regulatory catalysts, fueled by recent positive trial durability data and the broader market's growing interest in psychedelics. Community sentiment remains focused on the company's first-mover advantage, imminent commercialization timelines, and its potential as a prime candidate for acquisition by big pharma.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans

Cardio Diagnostics Holdings (NASDAQ: CDIO) is a precision cardiovascular medicine company leveraging epigenetics, genetics and artificial intelligence. The company discussed innovative approaches to cardiovascular disease prevention, risk assessment and cost management at multiple national benefits conferences this month. Cardio’s presentations highlight how advanced cardiovascular risk assessment and detection tools can support both improved health outcomes and more […]

Cardio Diagnostics Holdings (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks

When most people think about their risk for heart disease, they think about family history. Did a parent or grandparent have a heart attack? Is heart disease “in their genes”? It’s an understandable assumption, and genetics does play a role in cardiovascular risk. But a growing body of research suggests that DNA sequence alone tells […]

Cardio Diagnostics Holdings (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection

Coronary heart disease (“CHD”) remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume.&#160;Cardio Diagnostics Holdings (NASDAQ: CDIO)&#160;reports&#160;that approximately 50% of individuals with coronary heart disease do not present with traditional risk factors and conventional [&#8230;]

Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians

Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas Healthcare Physicians, an independent physician association serving managed care populations across Los Angeles and Orange counties, will provide coverage for the company’s Epi+Gen CHD(TM) and PrecisionCHD(TM) tests for eligible members with prior authorization. The coverage expands access to physician-ordered blood tests [&#8230;]

Atlas Healthcare Physicians to Cover Cardio Diagnostics Precision Cardiovascular Medicine Tests Across Its Network

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas Healthcare Physicians (AHP), a community-driven, independent physician association (IPA) based in Southern California, will cover Cardio Diagnostics tests, Epi+Gen CHD and...

Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI

Heart disease has held the grim distinction of being the leading cause of death in the United States for decades, and despite advances in medicine, the problem is getting worse, not better. According to the&#160;American Heart Association (“AHA”), cardiovascular disease&#160;accounted&#160;for more than 940,000 deaths in the United States in 2022, maintaining its position as the [&#8230;]

Cardio Diagnostics Holdings (NASDAQ: CDIO) Aligns with Growing Shift Toward Predictive, Precision Medicine

Cardio Diagnostics Holdings (NASDAQ:&#160;CDIO)&#160;is focused on personalized, data-driven cardiovascular care powered by artificial intelligence, epigenetics and genetic insights. “Through its proprietary platform and expanding testing capabilities, the company is pursuing a future in which prevention becomes more accessible, scalable and actionable before life-threatening cardiac events occur,” reads a recent article. “The company’s vision reflects a [&#8230;]

Cardio Diagnostics Holdings (NASDAQ: CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs

A single heart attack or major cardiovascular event can have consequences that extend far beyond a patient’s health, affecting employers, insurers and healthcare systems through higher medical costs, lost productivity and long-term care expenses. As cardiovascular disease continues to drive a significant share of healthcare spending, organizations responsible for employee benefits are seeking new strategies [&#8230;]

Cardio Diagnostics (NASDAQ: CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection

Cardio Diagnostics Holdings (NASDAQ:&#160;CDIO)&#160;was featured in a recent article that discusses the urgent need for more effective tools to identify risk earlier and guide personalized intervention strategies for cardiovascular disease. The piece reads, “Cardio Diagnostics is rising to the challenge by developing a suite of clinical, population health and biopharma solutions designed to leverage artificial [&#8230;]

Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences

Cardio Diagnostics Holdings (NASDAQ: CDIO)&#160;announced it will exhibit at four national benefits conferences in June to engage employers, brokers, union trustees and plan administrators on strategies to address cardiovascular disease, a leading driver of health plan costs and workforce productivity losses. The company will showcase its AI-powered cardiovascular risk assessment offerings, including Epi+Gen CHD(TM), PrecisionCHD(TM) [&#8230;]

Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. It also develops and commercializes a series of products for major types of cardiovascular disease and associated co-morbidities including coronary heart disease (CHD), stroke, heart failure, and diabetes. The company was founded in 2007, and is headquartered in Chicago, IL.

Cardio Diagnostics Holdings Inc

Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024

Equity

Bullish Sentiment

Investment platforms / apps

Social media

Financial media 

Artificial Intelligence

Where do you usually get information about ETFs? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

Where do you usually get information about ETFs? 
 
*Sponsored by Calamos and S&P Global

Current Price	$1.74
Prev Close	$1.72
Open	$1.75
Dividend Yield	0.00%
50-Day Moving Average	$1.88
Beta	2.08
Avg. Volume	55,762.76
PE Ratio	-0.51

52-Week High	$7.91
52-Week Low	$0.97
Market Capitalization	$5.09M
EPS (Annual)	-$3.71
Price to Book	0.57
Revenue Per Employee	$988.33

Feed

News

Sentiment

Earnings

Fundamentals

Info

CDIOCardio Diagnostics Holdings Inc

Latest CDIO News